View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Diabetes News

SPONSORED CONTENT
Save
SPONSORED CONTENT
February 01, 2021
2 min read
Save

Evidence suggests patients on low-carb diets achieve type 2 diabetes remission

Evidence suggests patients on low-carb diets achieve type 2 diabetes remission

Patients with diabetes who consistently followed a low-carbohydrate diet for 6 months achieved a higher rate of remission — 32% — compared with mostly low-fat diets, according to a systematic review and meta-analysis.

SPONSORED CONTENT
January 27, 2021
3 min read
Save

Diabetes complications differ according to ethnicity, disease-related subgroups

Diabetes complications differ according to ethnicity, disease-related subgroups

Risks for diabetes complications vary according to subgroups related to age of onset, HbA1c, obesity and insulin use, and there are racial and ethnic disparities in the composition of each subgroup, according to study data.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
January 12, 2021
1 min read
Save

FDA grants priority review to diabetic kidney disease treatment from Bayer

FDA grants priority review to  diabetic kidney disease treatment from Bayer

The FDA has granted priority review to a new drug application for finerenone, a non-steroidal mineralocorticoid receptor inhibitor antagonist, for the treatment of diabetic kidney disease.

SPONSORED CONTENT
January 08, 2021
1 min read
Save

SGLT2 inhibitors ‘best choice’ for reducing AKI risk vs other glucose-lowering drugs

SGLT2 inhibitors ‘best choice’ for reducing AKI risk vs other glucose-lowering drugs

For patients with type 2 diabetes, SGLT2 inhibitors conferred a lower risk of developing AKI than use of GLP-1 receptor agonists or dipeptidyl peptidase-4 inhibitors, according to a network meta-analysis of clinical trials.

SPONSORED CONTENT
January 04, 2021
1 min read
Save

‘Relatively high proportion’ of patients with diabetes experience rapid CKD progression

‘Relatively high proportion’ of patients with diabetes experience rapid CKD progression

Approximately 10% to 17% of patients with type 2 diabetes and newly identified chronic kidney disease had their condition worsen within 2 years, according to a study published in the Clinical Kidney Journal.

SPONSORED CONTENT
December 06, 2020
1 min read
Save

Statins for primary prevention associated with CV benefit in older adults

Statins for primary prevention associated with CV benefit in older adults

Statin use for primary prevention was associated with CV benefits in older adults, without significant risk for development of new-onset diabetes, according to research published in the American Journal of Medicine.

SPONSORED CONTENT
December 03, 2020
2 min read
Save

Spinal cord stimulators provide relief from diabetic neuropathic pain

Spinal cord stimulators provide relief from diabetic neuropathic pain

An implanted 10 kHz spinal cord stimulator, when used in tandem with opioids and other pain relievers, provided patients relief from diabetic neuropathic pain, data show.

SPONSORED CONTENT
November 24, 2020
2 min read
Save

Diabetes Awareness Month: 10 updates on its detection, risks, management

Diabetes Awareness Month: 10 updates on its detection, risks, management

Diabetes reduces life expectancy in middle-aged adults by up to 10 years and independently increases the risk for death from cancer, CVD and renal disease as much as threefold, according to the Lancet Commission on diabetes.

SPONSORED CONTENT
November 18, 2020
1 min read
Save

Hypertension, diabetes ‘common’ in patients with neurological complications of COVID-19

Hypertension, diabetes ‘common’ in patients with neurological complications of COVID-19

Among patients with COVID-19, those who had hypertension or type 2 diabetes were more likely to develop neurological conditions associated with the infectious disease, data from a small study show.

SPONSORED CONTENT
November 17, 2020
5 min read
Save

SCORED/SOLOIST: Dual SGLT inhibitor shows new CV benefits in type 2 diabetes

SCORED/SOLOIST: Dual SGLT inhibitor shows new CV benefits in type 2 diabetes

Adults with type 2 diabetes and worsening HF or at CV risk assigned the dual SGLT1/SGLT2 inhibitor sotagliflozin saw reduced risk for CV death and hospitalization or urgent visits for HF compared with placebo.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails